198 related articles for article (PubMed ID: 31640185)
1. Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer.
Blondel A; Benberghout A; Pedeux R; Ricordel C
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31640185
[TBL] [Abstract][Full Text] [Related]
2. The ING tumor suppressors in cellular senescence and chromatin.
Ludwig S; Klitzsch A; Baniahmad A
Cell Biosci; 2011 Jul; 1(1):25. PubMed ID: 21767350
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of Growth Factors Regulate Cellular Senescence.
Ghafouri-Fard S; Taheri M; Baniahmad A
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804879
[TBL] [Abstract][Full Text] [Related]
4. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.
Doyon Y; Cayrou C; Ullah M; Landry AJ; Côté V; Selleck W; Lane WS; Tan S; Yang XJ; Côté J
Mol Cell; 2006 Jan; 21(1):51-64. PubMed ID: 16387653
[TBL] [Abstract][Full Text] [Related]
5. Focus-ING on DNA Integrity: Implication of ING Proteins in Cell Cycle Regulation and DNA Repair Modulation.
Archambeau J; Blondel A; Pedeux R
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878273
[TBL] [Abstract][Full Text] [Related]
6. Biological Functions of the ING Proteins.
Dantas A; Al Shueili B; Yang Y; Nabbi A; Fink D; Riabowol K
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31752342
[TBL] [Abstract][Full Text] [Related]
7. ING2, a tumor associated gene, enhances PAI‑1 and HSPA1A expression with HDAC1 and mSin3A through the PHD domain and C‑terminal.
Ohkouchi C; Kumamoto K; Saito M; Ishigame T; Suzuki SI; Takenoshita S; Harris CC
Mol Med Rep; 2017 Nov; 16(5):7367-7374. PubMed ID: 28944862
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.
Pan YQ; Zhang X; Xu DP; Bao WG; Lin AF; Xu HH; Yan WH
Neoplasma; 2014; 61(4):468-75. PubMed ID: 24712846
[TBL] [Abstract][Full Text] [Related]
9. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
10. Sumoylation of ING2 regulates the transcription mediated by Sin3A.
Ythier D; Larrieu D; Binet R; Binda O; Brambilla C; Gazzeri S; Pedeux R
Oncogene; 2010 Nov; 29(44):5946-56. PubMed ID: 20676127
[TBL] [Abstract][Full Text] [Related]
11. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
12. ING2 (inhibitor of growth protein-2) plays a crucial role in preimplantation development.
Zhou L; Wang P; Zhang J; Heng BC; Tong GQ
Zygote; 2016 Feb; 24(1):89-97. PubMed ID: 25672483
[TBL] [Abstract][Full Text] [Related]
13. Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.
Ythier D; Brambilla E; Binet R; Nissou D; Vesin A; de Fraipont F; Moro-Sibilot D; Lantuejoul S; Brambilla C; Gazzeri S; Pedeux R
Lung Cancer; 2010 Aug; 69(2):180-6. PubMed ID: 19962781
[TBL] [Abstract][Full Text] [Related]
14. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.
Karthik S; Sankar R; Varunkumar K; Ravikumar V
Biomed Pharmacother; 2014 Apr; 68(3):327-34. PubMed ID: 24485799
[TBL] [Abstract][Full Text] [Related]
15. INGs are potential drug targets for cancer.
Zhang R; Jin J; Shi J; Hou Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):189-197. PubMed ID: 27544390
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics in non-small cell lung cancer: from basics to therapeutics.
Ansari J; Shackelford RE; El-Osta H
Transl Lung Cancer Res; 2016 Apr; 5(2):155-71. PubMed ID: 27186511
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and characterization of α, β-unsaturated carboxylic acid, and its urea based derivatives that explores novel epigenetic modulators in human non-small cell lung cancer A549 cell line.
Chidambaram A; Sundararaju K; Chidambaram RK; Subbiah R; Jayaraj JM; Muthusamy K; Vilwanathan R
J Cell Physiol; 2018 Jul; 233(7):5293-5309. PubMed ID: 29215703
[TBL] [Abstract][Full Text] [Related]
18. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
Lai JP; Yu C; Moser CD; Aderca I; Han T; Garvey TD; Murphy LM; Garrity-Park MM; Shridhar V; Adjei AA; Roberts LR
Gastroenterology; 2006 Jun; 130(7):2130-44. PubMed ID: 16762634
[TBL] [Abstract][Full Text] [Related]
19. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
[TBL] [Abstract][Full Text] [Related]
20. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.
Dhordain P; Lin RJ; Quief S; Lantoine D; Kerckaert JP; Evans RM; Albagli O
Nucleic Acids Res; 1998 Oct; 26(20):4645-51. PubMed ID: 9753732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
